cbdMD (YCBD) Cash from Investing Activities (2016 - 2025)
cbdMD (YCBD) posted Cash from Investing Activities of -$164802.0 for Q4 2025, down 5777.39% sequentially from -$2804.0 in Q3 2025, and little changed YoY from -$165219.1 in Q4 2024.
cbdMD (YCBD) Cash from Investing Activities (2016 - 2025) Analysis & Trends
cbdMD has reported Cash from Investing Activities for 10 years, with the latest figure at -$164802.0 in Q4 2025.
- Quarterly Cash from Investing Activities changed 0.25% year-over-year to -$164802.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$184587.0 (up 31.58% YoY) and the FY2025 annual result came in at -$184172.0, up 36.5% from the prior year.
- Cash from Investing Activities retreated to -$164802.0 in Q4 2025 per YCBD's latest filing, from -$2804.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $1.1 million in Q1 2023 and troughed at -$2.0 million in Q3 2021.
- A 5-year average of -$190733.5 and a median of -$120180.0 in 2023 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 921.25% in 2021, down 820.91% in 2021.
- Over 5 years, Cash from Investing Activities stood at -$231030.0 in 2021, then grew by 23.23% to -$177370.0 in 2022, then slipped by 4.1% to -$184635.0 in 2023, then increased by 10.97% to -$164387.0 in 2024, then slipped by 0.25% to -$164802.0 in 2025.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$164802.0, -$2804.0, and -$1475.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -164,802.00 |
| Dec 31, 2025 | -164,802.00 |
| Sep 30, 2025 | -2,804.00 |
| Sep 30, 2025 | -2,804.00 |
| Jun 30, 2025 | -1,475.00 |
| Jun 30, 2025 | -1,475.00 |
| Mar 31, 2025 | -15,506.00 |
| Mar 31, 2025 | -15,506.00 |
| Dec 31, 2024 | -164,387.00 |
| Dec 31, 2024 | -164,387.00 |
| Sep 30, 2024 | -110,000.00 |
| Sep 30, 2024 | -110,000.00 |
| Mar 31, 2024 | 4,620.00 |
| Mar 31, 2024 | 4,620.00 |
| Dec 31, 2023 | -184,635.00 |
| Dec 31, 2023 | -184,635.00 |
| Sep 30, 2023 | -120,180.00 |
| Sep 30, 2023 | -120,180.00 |
| Jun 30, 2023 | -102,389.00 |
| Jun 30, 2023 | -102,389.00 |